entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 04:11:36 - browse：53

Ford F-150 Recall — FILE - A 2021 F-150 pickup truck at a Ford dealer in southeast Denver, Oct. 24, 2021. Ford is recalling more than 870,000 newer F-150 pickup trucks in the U.S. because the electric parking brakes can turn on unexpectedly. The recall covers certain pickups from the 2021 through 2023 model years with single exhaust systems. Ford's F-Series pickups are the top-selling vehicles in the U.S. (AP Photo/David Zalubowski, File)The Associated Press

DEARBORN, Mich. -- Ford is recalling more than 870,000 newer F-150 pickup trucks in the U.S. because the electric parking brakes can turn on unexpectedly.

The recall covers certain pickups from the 2021 through 2023 model years with single exhaust systems. Ford's F-Series pickups are the top-selling vehicles in the U.S.

The company says in documents posted by government safety regulators Friday that a rear wiring bundle can come in contact with the rear axle housing. That can chafe the wiring and cause a short circuit, which can turn on the parking brake without action from the driver, increasing the risk of a crash.

Drivers may see a parking brake warning light and a warning message on the dashboard.

Ford says in documents that it has 918 warranty claims and three field reports of wire chafing in North America. Of these, 299 indicated unexpected parking brake activation, and 19 of these happened while the trucks were being driven.

The company says it doesn't know of any crashes or injuries caused by the problem.

Dealers will inspect the rear wiring harness. If protective tape is worn through, the harness will be replaced. If the tape isn't worn, dealers will install a protective tie strap and tape wrap.

Owners will be notified by letter starting Sept. 11.

Owners with questions can call Ford customer service at (866) 436-7332.

Previous article： Virginia high school admissions case could be legal follow
Next article： It's been 20 years since Dolly the sheep. Where's my clone?

focus

explore

WSS

Drug for rare kidney disease narrowly misses mark in clinical trial

CommonSpirit Health keeps growing, even as it loses money

After affirmative action ruling, medical educators look to 'holistic review'

Biotech stock slump in 2023: awaiting the turnaround

In age of alternative facts, a scholarly course on calling out crap

Thermo Fisher plant for manufacturing gene therapies to expand

focus

entertainment

Wikipedia

How one medical school became remarkably diverse

Microbiome research is starting to find links to chronic diseases

The cancer drug shortage isn’t new — and neither are the solutions

Anesthesiologist group: stop taking Ozempic before surgery

State Dept. review finds Biden bears some blame for Afghanistan failures

Intarcia’s device

Drug repurposing or repositioning? The language matters

How one medical school became remarkably diverse

Trump demands the U.S. pay no more for drugs than other countries … again

Hollywood unions extend contract negotiations for actors

focus

FDA panel to weigh approval of NurOwn, controversial ALS drug

At least 13 dead in Texas as scorching temps continue

BioMarin wins approval for gene therapy to treat hemophilia A

Second xenotransplant done with gene

Psychedelics group wrestles with new pharma identity

Senate HELP committee spars over health care workforce policies

hotspot

focus

explore

leisure time